ghk-cu long-term use studies tolerance The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline Peptide Therapy for Inflammation: A
Description
Patience pays off

Occasional reports include temporary fatigue or lethargy (5-10% of users), mild headaches in the first few days of use, slight water retention, or transient flushing at injection sites

For patients, this resulted in a significantly lower risk of moderate to severe exacerbations with Dupixent, by 20% in BOREAS and 29% in NOTUS

R.CrouchP

That number should alarm you
Currently, roxadustat have received marketing authorization in China, Japan, European Medicines Agency and other countries, while the FDA denied approval of roxadustat due to safety concerns
